Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021 Customer orders backlog of over $1.5 million at August 31, 2021 Following close of first fiscal quarter 2022, Walmart began online sales of Biomerica’s EZ… Read More
Quarterly Reports
Biomerica Reports Fiscal 2021 Year End Results
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020. InFoods IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks. Biomerica receives multiple notices of allowance for patents covering the InFoods Technology Platform providing patent protection through… Read More
3rd Quarter Financials — April 15, 2020
3rd Quarter Financials — April 15, 2020
2nd Quarter Financials — January 15, 2020
IRVINE, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,596,408 for the three months ended November 30, 2019, compared to $1,500,791 for the same period in the previous year, an increase of… Read More
1st Quarter Financials — October 16, 2019
Irvine, Calif. — October 16, 2019 — Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,194,415 for the three months ending August 31, 2019, compared to $1,272,870 for the same period in the previous year. Net loss for the… Read More
3rd Quarter Financials 2019 — April 16, 2019
IRVINE, California, — April 16, 2019 — Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $4,034,822 for the nine months ending February 28, 2019, compared to $4,433,785 for the period ended February 28, 2018. Sales for the three months… Read More